No CrossRef data available.
Article contents
William Craig, MD, responds to Dr. Silver'squestion
Published online by Cambridge University Press: 21 June 2016
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
- Type
- Departments
- Information
- Copyright
- Copyright © The Society for Healthcare Epidemiology of America 1989
References
3.
Kothari, T, Keyes, MT, Brooks, N, et al:
Pseudomonas cepacia septic arthritis due to intro-articular injections of methylprednisolone. Can Med Assoc J.
1977;116:1230–1232.Google Scholar
4.
Centers for Disease Control: Group A streptococcal abscesses after DTP immunization—Georgia. MMWR.
1982;31:519–526.Google Scholar
5.
Sheth, NK, Post, GT, Wisniewaki, TR, et al: Multidose vials versus single dose vials: A study in sterility and cost-effectiveness. J Clin Microbiol.
1983;17:377–379.Google Scholar
6.
Longfield, R, Longfield, J, Smith, LP, et al: Multidose medication vial sterility: An in-use study and a review of the literature. Infect Control.
1984;5:165–169.Google Scholar
7.
Schubert, A, Hyarns, KC, Longfield, RN: Sterility of anesthetic multiple-dose vials after opening. Anesthesiology
1985;62:634–636.Google Scholar
8.
Bawden, JC, Jacobson, JA. Jackson, JC, et al: Sterility and use patterns of multiple-dose vials. Am J Hosp Pharm.
1982;39:294–297.Google Scholar
9.
Highsmith, AK. Greenhood, GP, Allen, JR: Growth of nosocomial pathogens in multiple-dose parenteral medication vials, J Clin Microblol.
1982;15:1024–1028.Google Scholar
10.
Longfield, RN, Smith, LP, Longfield, JN, et al: Multiple-dose vials: Persistence of bacterial contaminants and infection control implications. Infect Control.
1985;6:194–199.Google Scholar
You have
Access